Ladd, Healthequity evp, sells $564k in hqy stock

Delano Ladd, Executive Vice President and General Counsel at HealthEquity, Inc. (NASDAQ:HQY), a $8.27 billion market cap healthcare technology company with a perfect Piotroski Score of 9, sold 5,999 shares of common stock on September 19, 2025, according to a Form 4 filing with the Securities and Exchange Commission. InvestingPro data shows the company maintains a "GREAT" financial health rating of 3.48/5. The sales, executed under a pre-arranged 10b5-1 trading plan, resulted in total proceeds of $564647.

The shares were sold in multiple transactions at prices ranging from $93.9137 to $95.7. Specifically, 5,000 shares were sold at a weighted average price of $93.9137, in a range between $93.52 and $94.51. An additional 971 shares were sold at a weighted average price of $95.0603, in a range between $94.70 and $95.67. The remaining 29 shares were sold at $95.70 each.

Following the reported transactions, Ladd directly owns 79,456 shares of HealthEquity, Inc. For comprehensive insider trading analysis and 13 additional key insights about HQY, visit InvestingPro.

In other recent news, HealthEquity Inc. reported robust financial results for the second quarter of fiscal year 2026. The company’s earnings per share (EPS) came in at $1.08, surpassing analyst expectations of $0.92. Revenue for the quarter was $325.9 million, exceeding the anticipated $320.74 million. These figures highlight HealthEquity’s strong performance and have been positively received by investors. The company has not only met but exceeded the financial forecasts set by analysts. This financial performance is a significant development for HealthEquity, reflecting its operational strength. Investors and analysts alike will be watching closely to see how the company continues to perform in the upcoming quarters.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.